UPMC Enterprises
Investor profile
UPMC Enterprises has backed 3 European tech companies across 5 funding rounds between 2020 and 2025, joining rounds totalling €302M. Most active in Healthtech. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
3
backed
Active span
2020–2025
6 yrs
Total round €
€302M
sum of rounds joined
Deals by year
distinct rounds / yearUPMC Enterprises — deals by year — interactive chart.
Data table
| UPMC Enterprises — deals by year | |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Top sectors
by dealsUPMC Enterprises — top sectors — interactive chart.
Data table
| UPMC Enterprises — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by dealsUPMC Enterprises — stages — interactive chart.
Data table
| UPMC Enterprises — stages | |
|---|---|
| Series B | 3 |
| Series C | 1 |
| Other | 1 |
Countries
by dealsUPMC Enterprises — countries — interactive chart.
Data table
| UPMC Enterprises — countries | |
|---|---|
| France | 2 |
| Switzerland | 2 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Noema Pharma | Switzerland | 2 | €134M |
| Sparingvision | France | 2 | €120M |
| Ultromics | UK | 1 | €48M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Noema Pharma | Series B | €105M | 2023-03 |
| Sparingvision | Series B | €75M | 2022-09 |
| Ultromics | Series C | €48M | 2025-07 |
| Sparingvision | Other | €45M | 2020-10 |
| Noema Pharma | Series B | €29M | 2024-12 |